The Investor Catalyst Hub, part of the ARPANET-H nationwide health innovation network, aims to scale health research and venture investment ecosystem capabilities, disrupt traditional care models, and create new delivery pathways. Through the Investor Catalyst Hub, VentureWell supports the Advanced Research Projects Agency for Health (ARPA-H) in navigating the complexities of the business, transition, and regulatory landscapes and provides resources to help performers bring game-changing potential solutions to market to solve big problems in health.
Learn more about the Investor Catalyst Hub, including the latest ARPA-H funding news and spoke engagement opportunities, at https://investorcatalysthub.org/.
What Is VentureWell’s Role in the ARPA-H Investor Catalyst Hub?
VentureWell is the consortium management firm for the Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub. ARPA-H is a research funding agency that supports transformative biomedical and health breakthroughs—ranging from the molecular to the societal—to provide health solutions for all.
Read more about VentureWell’s role in the announcement of VentureWell as manager of Investor Catalyst Hub.
How To Engage
Is your organization interested in joining a nationwide network of spokes?
If you are interested in the ARPA-H Investor Catalyst Hub, apply to become an Investor Catalyst Hub spoke, and join a nationwide network of experts from government, industry, finance, healthcare, and academia collaborating to accelerate the commercialization of groundbreaking health innovations.